Alkermes has decided to expand the number of retail pharmacies and clinics where patients can receive access to Aristada (aripiprazole lauroxil) and Vivitrol (naltrexone extended-release injectable suspension).
Up to 75,000 more people could die from drug or alcohol misuse and suicide during the COVID-19 pandemic.
Alcohol consumption frequency in the entire sample and alcohol consumption amount in regular drinkers were genetically and phenotypically correlated, although genetic correlations between the 2 measures and external phenotypes displayed opposite directions.
Death certificate data suggest that alcohol-related mortality increased in the United States between 1999 and 2017.
From 2011 to 2017, there was an increase in the total annual number of binge drinks per adult who reported binge drinking.
Alcohol-attributable death rates were highest in Eastern Europe, sub-Saharan Africa, and countries with low human development indices (HDIs). Across countries, alcohol use disproportionately affected young people and men.
Twelfth-grade binge drinking predicts early adulthood risky driving practices and high-risk drinking in early adulthood.
While claims about the benefits of Vivitrol were clearly presented in the ad, serious risks, such as vulnerability to opioid overdose, were not communicated.
The data reflect the lasting effect of gunshot wounds on victims, with poor physical and psychosocial outcomes after 5 years, indicating that the burden of gun violence extends beyond mortality and economic cost.
Investigators extracted data from 8 waves of the Monitoring the Future study, which annually surveyed approximately 17,000 US high school students starting in 1975.
